Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 519 - Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups or
Patents for C07D 519 - Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups or (11,041)
11/2012
11/28/2012CN102803265A Pyrrolopyrazine kinase inhibitors
11/28/2012CN102796125A Tazobactam ampicillin amide composite, its preparation method and application
11/28/2012CN102796124A Di-beta-carboline alkali compound and preparation method, medicinal composition and application thereof
11/28/2012CN101667626B Organic electroluminescent devices and metal complex compounds
11/28/2012CN101432278B Diketo-piperazine and piperidine derivatives as antiviral agents
11/27/2012US8318450 Optically-detectable enzyme substrates and their method of use
11/22/2012WO2012156367A1 Amino-substituted imidazopyridazines as mknk1 kinase inhibitors
11/22/2012US20120294901 Novel cochleate formulations
11/22/2012US20120294885 Toll-like receptor-7 and -8 modulatory 1h imidazoquinoline derived compounds
11/22/2012CA2836203A1 Amino-substituted imidazopyridazines as mknk1 kinase inhibitors
11/21/2012EP2524913A1 Nitrogenated heterocyclic ring derivative and organic electroluminescent element comprising same
11/21/2012CN102791714A N-(imidazopyrimidin-7-yl)-heteroarylamide derivatives and their use as PDE10A inhibitors
11/21/2012CN102791712A Pyrazolopyrimidine derivative
11/21/2012CN102786536A Sulbactam amoxicillin amide complex for treatment of acute bacterial infection of pig and synthesis method
11/21/2012CN102786535A Polymerization aaptamine alkaloid compounds, preparation method thereof and application of polymerization aaptamine alkaloid compounds
11/20/2012US8314217 Cross-linked glycopeptide-cephalosporin antibiotics
11/15/2012WO2012154274A1 Triazolopyridine compounds as pim kinase inhibitors
11/15/2012WO2012154194A1 Piperidine derivatives and compositions for the inhibition of nicotinamide phosphoribosyltransferase (nampt)
11/15/2012WO2012153796A1 Pyrimido-diazepinone compound
11/15/2012WO2012153780A1 Novel compound, material for organic electroluminescence device, and organic electroluminescence device
11/15/2012CA2834745A1 Piperidine derivatives and compositions for the inhibition of nicotinamide phosphoribosyltransferase (nampt)
11/15/2012CA2828269A1 Triazolopyridine compounds as pim kinase inhibitors
11/13/2012US8309731 Electronic device including phenanthroline derivative
11/13/2012US8309552 Immunomodulating heterocyclic compounds
11/08/2012WO2011114271A8 2,3 dihydro- 1h - inden- 1 - yl -2,7 -diazaspiro [ 3.5 ] nonane derivatives and their use as antagonists or inverse agonists of the ghrelin receptor
11/08/2012US20120283284 Melonine bisindole compounds, pharmaceutical compositions, preparation method and use thereof
11/07/2012EP2520574A1 Amiloride analogues substituted on the cyclic guanidine moiety as ENaC blockers for treating respiratory diseases
11/07/2012CN102766149A Preparation method of vinorelbine tartrate
11/07/2012CN101583622B Inhibitors for disrupting the interaction of ubiquitination related enzymes and uses thereof
11/06/2012US8304283 Method for producing organic electronic device including converting a precursor for a semiconductor layer
11/06/2012CA2558195C 11-hydroxy-5h-pyrrolo[2,1-c][1,4]benzodiazepin-5-one derivatives as key intermediates for the preparation of c2 substituted pyrrolobenzodiazepines
11/01/2012WO2012147952A1 Cathode catalyst for air secondary battery and air secondary battery
11/01/2012WO2012147773A1 Novel cephem compound having catechol or pseudo-catechol structure
11/01/2012WO2012147568A1 Organic electroluminescent element
11/01/2012WO2012145981A1 Adamantane or adamantane-like compounds as antitumor agents
11/01/2012CA2833121A1 Novel cephem compound having catechol or pseudo-catechol structure
10/2012
10/31/2012EP2518073A1 Compounds for the treatment of Hepatitis C
10/31/2012EP2516438A2 Compounds and methods for kinase modulation, and indications therefor
10/31/2012EP2516433A1 Substituted n-(1h-indazol-4-yl)imidazo[1, 2-a]pyridine-3- carboxamide compounds as cfms inhibitors
10/31/2012EP2515654A1 Novel ergoline analogs
10/31/2012CN102762576A Benzoxazepin pi3k inhibitor compounds and methods of use
10/31/2012CN102757446A Synthesis method of pyranocoumarin derivatives
10/31/2012CN102040616B Preparation method of cefozopran hydrochloride
10/26/2012WO2012145173A1 Substituted oligoazacarbazoles for light emitting diodes
10/26/2012WO2012143813A1 Pyrazolospiroketone derivatives for use as acetyl - coa carboxylase inhibitors
10/26/2012WO2012143144A1 Pyrazolo [4, 3-d] pyrimidines useful as kinase inhibitors
10/26/2012WO2012143081A1 Conjugated polymers
10/26/2012WO2012143080A2 Materials for organic electroluminescent devices
10/26/2012CA2831634A1 Pyrazolo [4,3-d] pyrimidines useful as kinase inhibitors
10/26/2012CA2831380A1 Pyrazolospiroketone derivatives for use as acetyl-coa carboxylase inhibitors
10/25/2012US20120270855 Thieno- and furo-pyrimidine modulators of the histamine h4 receptor
10/25/2012US20120270841 Diazonamide Analogs
10/24/2012EP2513119A1 3,4,4A,10B-TETRAHYDRO-1H-THIOPYRANO-[4, 3-c]ISOQUINOLINE DERIVATIVES
10/24/2012EP2513109A1 Heterocyclic compounds and their uses
10/24/2012EP2513071A1 Thiazole derivatives for treating diseases such as cancer
10/24/2012EP2513059A1 Inhibitors of akt activity
10/24/2012CN102754238A 有机电致发光元件 Organic electroluminescent element
10/24/2012CN102753559A Conjugates of pyrrolo[1,4]benzodiazepine dimers as anticancer agents
10/24/2012CN102746325A Compound 1,10-N-decylene lycorine dibromo salt, pharmaceutical composition and application thereof in medicine
10/24/2012CN102746304A Purinamine compound and preparation method thereof
10/24/2012CN102746297A Oxazolidinone antibiotics
10/24/2012CN102746296A Oxazolidinone antibiotics
10/23/2012US8293902 Quinazoline compounds
10/23/2012US8293139 Charge transport compositions and electronic devices made with such compositions
10/18/2012WO2012142460A1 Naphthalene-diimide-heterocycle-naphthalene diimide oligomers as organic semiconductors and transistors therefrom
10/18/2012US20120264906 Semiconducting compounds and devices incorporating same
10/17/2012EP2511360A1 Organic light-emitting material and organic light-emitting element
10/17/2012CN1922171B Pyrimidine derivative
10/17/2012CN102741270A Cyclic peptide inhibitors of hepatitis c virus replication
10/17/2012CN102741249A Hetaryl-[1,8]naphthyridine derivatives
10/17/2012CN102731534A Preparation method of biapenem
10/16/2012US8287769 Charge transport compositions and electronic devices made with such compositions
10/11/2012US20120258973 Disubstituted heteroaryl-fused pyridines
10/11/2012US20120258958 Azaindoles useful as inhibitors of jak and other protein kinases
10/10/2012EP2508526A1 Spiroalkene carboxamide derivatives and their use as chemokine receptor modulators
10/10/2012EP2508204A2 Remedies for diseases caused by vascular contraction or dilation
10/10/2012CN102725291A Bicyclic pyridines and analogs as sirtuin modulators
10/04/2012WO2012133802A1 Novel furanone derivative
10/04/2012WO2012131084A1 Triaryl- and triheteroaryl- benzene monomers and polymers
10/04/2012WO2012130915A1 Spiroalkene carboxamide derivatives and their use as chemokine receptor modulators
10/04/2012US20120252799 Heterocyclic aromatic compounds useful as growth hormone secretagogues
10/04/2012US20120252780 Bicyclic pyridines and analogs as sirtuin modulators
10/04/2012CA2830148A1 Novel furanone derivatives
10/03/2012EP2504010A1 Fused bicyclic pyrimidine derivatives and methods of use thereof
10/03/2012EP2503890A1 Azabenzimidazoles as fatty acid synthase inhibitors
10/03/2012EP2503881A1 Fused tricyclic compounds and derivatives thereof useful for the treatment of viral diseases
10/03/2012CN1988956B Process for the photoactivation and use of a catalyst by an inverted two-stage procedure
10/03/2012CN102712658A N-containing heteroaryl derivatives as jak3 kinase inhibitors
10/03/2012CN102712653A Furopyridinyl-substituted 1,4-dihydropyridine derivatives and methods of use thereof
10/03/2012CN102712642A N-7 substituted purine and pyrazolopyrimidine compounds, compositions and methods of use
10/03/2012CN102702486A Mono-, oligo- and polythieno [3,2-b] thiophenes
10/03/2012CN102702147A Andrographolide analogue and application of andrographolide analogue to treatment
10/03/2012CN101580535B Hcv protease inhibitors
09/2012
09/27/2012WO2012129344A1 Fused tricyclic dual inhibitors of cdk 4/6 and flt3
09/27/2012WO2012128868A1 Cytotoxic benzodiazepine derivatives
09/27/2012WO2012128165A1 Resin-transfer-moldable terminal-modified imide oligomer using 2-phenyl-4,4'-diaminodiphenyl ether and having excellent moldability, mixture thereof, varnish containing same, and cured resin thereof and fiber-reinforced cured resin thereof made by resin transfer molding and having excellent heat resistance
09/27/2012WO2012126901A1 Benzoxazepin compounds selective for pi3k p110 delta and methods of use
09/27/2012WO2012065963A3 Antiviral condensed heterocyclic compounds
09/27/2012CA2830516A1 Fused tricyclic dual inhibitors of cdk 4/6 and flt3
09/27/2012CA2825966A1 Benzoxazepin compounds selective for pi3k p110 delta and methods of use
1 ... 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 ... 111